imatinib mesylate has been researched along with Granulomatosis, Lymphomatoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geh, I; Gregg, RJ; Pallalau, A; Salmons, N; Tanière, P; Woolhouse, I | 1 |
| Berneburg, M; Bitzer, M; Metzler, G; Müller-Hermelink, HK; Röcken, M; Weyrauch, S; Yazdi, AS | 1 |
2 other study(ies) available for imatinib mesylate and Granulomatosis, Lymphomatoid
| Article | Year |
|---|---|
Lymphomatoid granulomatosis in a patient previously diagnosed with a gastrointestinal stromal tumour and treated with imatinib.
Topics: Adult; Antineoplastic Agents; Benzamides; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lung Neoplasms; Lymphomatoid Granulomatosis; Lymphopenia; Male; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Tomography, X-Ray Computed | 2007 |
Lymphomatoid granulomatosis induced by imatinib-treatment.
Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Diseases; Lymphomatoid Granulomatosis; Piperazines; Pyrimidines; Skin Diseases | 2007 |